Has Shravani Durbhakula, MD received payments from drug or device companies?

Yes. Drug and device makers reported $353,124 in general payments to Shravani Durbhakula, MD across 479 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shravani Durbhakula, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shravani Durbhakula, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shravani Durbhakula, MD

Pain Medicine · Nashville, TNNPI 1447510771

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. GRT US Holding, Inc. accounts for 97.3% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $236,726 and has fallen 99.8% since, to $541 in 2025. Among pain medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$353,124in general payments, 2019–2025

Across 479 payments — averaging $737.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GRT US Holding, Inc.$344K
Nevro Corp.$5K
SPR Therapeutics, Inc$1K
Abbott$750
Saluda Medical Americas, Inc.$575
Boston Scientific$365
plus $1K from 10 others

$115,170in research payments, 2019–2025

Across 26 payments — averaging $4429.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Avanos Medical$115K

What the payments were for

Consulting fees$19,6076%
Speaking & faculty fees$205,94658%
Travel & lodging$114,34432%
Food & beverage$13,2124%
Entertainment$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GRT US Holding, Inc.	376	$343,749
Nevro Corp.	56	$5,194
SPR Therapeutics, Inc	11	$1,085
Abbott	7	$750
Saluda Medical Americas, Inc.	6	$575
Boston Scientific	5	$365
Vertos Medical, Inc.	2	$298
Medtronic	2	$284
Flowonix Medical Incorporated	2	$246
Averitas Pharma Inc.	5	$215
Nalu Medical, Inc.	2	$125
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$75
Camber Spine Technologies LLC	1	$58
Collegium Pharmaceutical, Inc.	1	$46
AbbVie	1	$44
Foundation Fusion Solutions, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Qutenza$339,279
Senza Spinal Cord Stimulation System$3,532
SPRINT PNS System$727
Proclaim Family of SCS IPGs$448
mild Device Kit$298
Evoke SCS$256
Accurian$169
Prometra II$146
Senza$132
Evoke$121
Eon Family of SCS IPGs$120
WAVEWRITER ALPHA$119
VANTA ADAPTIVESTIM$115
Omnia$112
SPECTRA WAVEWRITER$103
Nalu Neurostimulation System$101

How this compares

$353,124 in reported general payments places this provider in the 95th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024

$31,141

Medicare patients

Services billed

253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	12	$1,807
Tizanidine Hcl	19	$886
Naltrexone Hcl	25	$824
Duloxetine Hcl	41	$708
Pregabalin	13	$324
Meloxicam	20	$25

Paid to pharmacies, not to this prescriber.

Other pain medicine in Nashville

Herbert MeltzerNashville$43K
Marc HuntoonNashville$37K
Puneet MishraNashville$32K
Jeremy WalkerNashville$25K
Damita BryantNashville$18K
Tigran KesayanNashville$13K
Alex SchmidtNashville$10K
Christopher SobeyNashville$10K
Victor IsaacNashville$7K
Barbara SchooleyNashville$6K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →